- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05576948
Natural History of Cerebral Palsy Prospective Study
Understanding the Early Natural History of Cerebral Palsy - A Prospective Cohort Study
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Karen L Harpster, PhD
- Phone Number: 513-803-3604
- Email: karen.harpster@cchmc.org
Study Contact Backup
- Name: Kelly Greve, PhD
- Phone Number: (513) 636-3605
- Email: kelly.greve@cchmc.org
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Recruiting
- Cincinnati Children's Hospital Medical Center
-
Contact:
- Karen L Harpster, PhD, OTR/L
- Phone Number: 513-803-3604
- Email: karen.harpster@cchmc.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Infants will be included if they have a diagnosis of CP or "at high risk of CP" and under the age of 12 months.
Infants at high risk of CP as defined by any two (any combination) of the following:
- Neuroimaging predictive of a motor disability including the involvement of 1 or more of the following structures: sensori-motor cortex, Basal Ganglia, Posterior Limb of the Internal Capsule, pyramids.
- Trajectory of cramped synchronized general movements (GMs) on General Movement Assessment (GMA) OR absent fidgety GMs at fidgety age
Hammersmith Infant Neurological Exam (HINE) scores <57 @ 3months or <60 @ 6months or <63 @9 months
Infants will also be included if they meet BOTH of the following criteria (even if infants have a HINE score greater than the cut off scores stated above:
i. Unilateral brain injury on neuroimaging (magnetic resonance imaging (MRI) or cranial ultrasound (CUS)) predictive of CP ii. Clinical signs of asymmetry
Exclusion Criteria:
- Infants with progressive or neurodegenerative disorders or genetic disorders not associated with CP
- Infants with other disability diagnoses e.g. Down Syndrome
Study Plan
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Children with or at high risk of CP
Infants with a diagnosis of CP OR at high risk of CP as per the international Clinical Practice Guideline for early diagnosis of CP.
In order to develop prognostic curves for motor function a minimum of 3 data points are required per participant.
For this reason infants will be included if they are 12 months or younger (corrected age) at the time of enrolment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Motor skills
Time Frame: 3 months, 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
Peabody: Gross and Fine motor skills
|
3 months, 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
|
Change in Speech and Language skills
Time Frame: 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
Bayley Scales of Infant and Toddler Development
|
6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
|
Change in Cognitive skills
Time Frame: 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
Bayley Scales of Infant and Toddler Development
|
6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
|
Change in Neurologic assessment
Time Frame: 3 months, 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
Hammersmith Infant Neurological Examination
|
3 months, 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
|
Change in Musculoskeletal assessment
Time Frame: 3 months, 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
Modified Tardieu Scale
|
3 months, 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
|
Change in Musculoskeletal assessment
Time Frame: 9 months, 12 months, 18 months, 24 months (corrected age)
|
Australian Spasticity Assessment Scale
|
9 months, 12 months, 18 months, 24 months (corrected age)
|
|
Change in Musculoskeletal assessment
Time Frame: 18 months, 24 months corrected age
|
Hip X-ray
|
18 months, 24 months corrected age
|
|
Change in Vision
Time Frame: 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
Previas
|
6 months, 9 months, 12 months, 18 months, 24 months (corrected age)
|
|
Vision
Time Frame: 3 months corrected age
|
Ricci
|
3 months corrected age
|
|
Change in Sleep
Time Frame: 9 months, 12 months, 18 months, 24 months (corrected age)
|
Sleep disturbances Scale for Children
|
9 months, 12 months, 18 months, 24 months (corrected age)
|
|
Change in Feeding skills
Time Frame: 12 months, 18 months, 24 months (corrected age)
|
Dysphagia Disorder Survey
|
12 months, 18 months, 24 months (corrected age)
|
|
Change in Self Care
Time Frame: 6 months, 12 months, 18 months, 24 months (corrected age)
|
Pediatric Evaluation of Disability Inventory Computerized Assessment Test
|
6 months, 12 months, 18 months, 24 months (corrected age)
|
|
Change in Adaptive Behavior
Time Frame: 12 months, 18 months, 24 months (corrected age)
|
Infant Toddler Social Emotional Assessment
|
12 months, 18 months, 24 months (corrected age)
|
|
Change in Parent Well Being
Time Frame: 12 months, 18 months, 24 months (corrected age)
|
Depression, Anxiety and Stress Scale
|
12 months, 18 months, 24 months (corrected age)
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-0189
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.